Recruiting
Phase 1

LY4257496

Sponsor:

Eli Lilly and Company

Code:

NCT07114601

Conditions

Breast Neoplasms

Colorectal Neoplasms

Prostate Neoplasm

Endometrial Neoplasms

Neoplasm Metastasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY4257496

Standard of Care Anticancer Therapies

LY4257529

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-03. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2026-03-02.